UK Companies House feature
CATALENT OXFORD LIMITED
Cash
£2M
+159.2% vs 2023
Net assets
-£6M
-683.3% vs 2023
Employees
—
Average over period
Profit before tax
-£7M
+87.7% vs 2023
Profile
- Company number
- 13947744
- Status
- Active
- Incorporation
- 2022-03-01
- Last accounts made up
- 2024-06-30
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Net assets
2-year trend · vs UK Healthcare median
Accounts
2-year trend · latest 2024-06-30
| Metric | Trend | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£54,990,661 | -£1,596,964 | |
| Profit before tax | -£60,907,474 | -£7,465,731 | |
| Net profit | -£60,907,474 | -£7,465,731 | |
| Cash | £763,569 | £1,979,361 | |
| Total assets less current liabilities | £95,977,588 | £93,703,710 | |
| Net assets | £1,092,526 | -£6,373,205 | |
| Equity | £1,092,526 | -£6,373,205 | |
| Average employees | 17 | — | |
| Wages | £1,786,582 | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Morris Owen
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“This comprehensive approach-anchored by proactive market engagement, careful asset management, and strong financial backing-reinforces the Directors' conclusion that Catalent Oxford Limited remains a going concern despite its current non-trading status.”
Significant events
- “In December 2022, construction of the facility was halted due to a decline in demand from the intended customer, driven by changing market conditions.”
- “As of 5th February 2024, Catalent, Inc., the ultimate parent company, announced a merger agreement with Novo Holdings. Under this agreement, Novo Holdings will acquire Catalent, Inc. in an all-cash transaction expected to close by the end of calendar year 2024, subject to regulatory clearances and customary closing conditions.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CERON, Ramon Javier, Mr. | Director | 2023-10-02 | Aug 1969 | American |
| MCERLANE, David, Mr. | Director | 2025-08-29 | Jul 1973 | American,British |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOERMAN, Manja | Director | 2022-09-14 | 2023-07-27 |
| COMO, Andrea | Director | 2022-03-18 | 2022-09-14 |
| GARGIULO, Mario | Director | 2022-03-01 | 2023-04-28 |
| HOPSON, Ricky Wayne | Director | 2023-12-04 | 2025-08-29 |
| RILEY, Michael | Director | 2022-03-18 | 2022-09-14 |
| SMITH, Robert | Director | 2022-09-14 | 2023-12-31 |
| WALSH, Kirk | Director | 2022-03-18 | 2022-09-14 |
| ZAYAS, Ricardo | Director | 2023-06-20 | 2024-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Catalent Nottingham Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2025-12-23 | Active |
| Catalent Pharma Solutions Limited | Corporate entity | Shares 50–75%, Voting 50–75%, Appoints directors | 2022-03-01 | Active |
Filing timeline
Last 20 of 31 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-02-24 | CH01 | officers | change person director company with change date |
| 2025-12-23 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2025-12-23 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-11-17 | AP01 | officers | appoint person director company with name date |
| 2025-11-17 | TM01 | officers | termination director company with name termination date |
| 2025-09-08 | AD01 | address | change registered office address company with date old address new address |
| 2025-06-19 | AA01 | accounts | change account reference date company current extended |
| 2025-03-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-12-18 | AA | accounts | accounts with accounts type full |
| 2024-10-10 | TM01 | officers | termination director company with name termination date |
| 2024-03-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-02-19 | AA | accounts | accounts with accounts type full |
| 2024-01-23 | AP01 | officers | appoint person director company with name date |
| 2024-01-04 | TM01 | officers | termination director company with name termination date |
| 2023-11-03 | AP01 | officers | appoint person director company with name date |
| 2023-09-13 | TM01 | officers | termination director company with name termination date |
| 2023-08-18 | AP01 | officers | appoint person director company with name date |
| 2023-08-17 | TM01 | officers | termination director company with name termination date |
| 2023-03-14 | CS01 | confirmation-statement | confirmation statement with updates |
Credit score
Altman Z″ (private-firm) · reference 2024-06-30
-0.84
DISTRESS
Altman Z″
- Working capital / Total assets -0.105 × 6.56 = -0.69
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets -0.015 × 6.72 = -0.10
- Book equity / Total liabilities -0.056 × 1.05 = -0.06
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
34.2
COLD
/ 100
- Filings velocity 67
- Capital events 0
- Officer churn 50
- Headcount trajectory 50
- Accounts trajectory 0
- 8 filing(s) in last 12 months
- 1 appointed, 1 resigned (12mo)
- Net Assets -683% YoY